By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Embera NeuroTherapeutics, Inc. 

2031 Kings Highway
Suite 230
Shreveport  Louisiana  71103  U.S.A.
Phone: 318-213-0198 Fax: 318-213-0195


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Embera NeuroTherapeutics, Inc. Receives $11M Grant From National Institute on Drug Abuse (NIDA) For The Clinical Development Of EMB-001 For The Treatment Of Cocaine Addiction 7/26/2016 9:47:46 AM
Embera NeuroTherapeutics, Inc. Announces Successful Completion Of Phase 1 Clinical Trial Testing EMB-001, A Potential Novel Treatment For Addictions 1/6/2016 11:29:04 AM
Embera NeuroTherapeutics, Inc. Initiates Phase 1 Clinical Trial To Test EMB-001 As A Novel Treatment For Addictions 5/28/2015 9:45:54 AM
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015 11:45:39 AM
Embera NeuroTherapeutics, Inc. To Receive Grant For Clinical Trial Through New Crowd Funding Platform 7/1/2014 11:19:54 AM
Embera NeuroTherapeutics, Inc. and Collaborators Publish Paper in Psychopharmacology Supporting its Novel Drug Combination, EMB-001, for Smoking Cessation 3/16/2012 7:34:32 AM
Embera NeuroTherapeutics, Inc. Takes In $4.5 Million Series A Financing 8/15/2011 8:33:24 AM
Embera NeuroTherapeutics, Inc.' Lead Candidate, EMB-001, Supported by $3.9M Grant from National Institute on Drug Abuse (NIDA) 10/1/2010 10:10:46 AM
Embera NeuroTherapeutics, Inc.’ Lead Candidate, EMB-001, Supported by $3.9M Grant from National Institute on Drug Abuse 10/1/2010 6:32:28 AM
Embera NeuroTherapeutics, Inc. Forms Clinical Development Collaboration with Exponential Pharma Ventures 2/16/2010 9:47:56 AM
12
//-->